Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

Overview
Date Founded

2011

Headquarters

Else-Kröner-Straße 1,Bad Homburg, Hessen 61352

Type of Company

Public

Employees (Worldwide)

294K

Industries

Medical Products & Equipment
Hospitals & Patient Services

Company Description

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises dialysis products and healthcare services. The Fresenius Kabi segment specializes intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Contact Data
Trying to get in touch with decision makers at Fresenius SE & Co. KGaA? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer

Chief Legal & Compliance Officer, Insurance, Human Resources, Labor Relations Director

Chief Executive Officer Fresenius Medical Care

Chief Executive Officer Fresenius Kabi

Chief Executive Officer Fresenius Helios

Chief Executive Officer Fresenius Vamed

Head-Events

Head-External & Internal Communications

Head-Clinical Development-Fresenius BioTech

Director, Investor Relations

Supervisory Board

Former Chairman-Management Board & Chief Executive Officer at Allianz SE

Head-Company & Industry Politics at Vereinte Dienstleistungsgewerkschaft

Independent Chairman of the Supervisory Board at Fresenius SE & Co. KGaA

Director at Kühne + Nagel International AG

Head of Department, East German Operations at Commerzbank

Executive Vice President & Chief Medical Officer at UCB S. A.

Chairman-Group Works Council at VAMED AG

Medical Director at Universitätsklinikum Carl Gustav Carus Dresden

Member, Supervisory Board at Fresenius SE & Co. KGaA

Member, Supervisory Board at Fresenius SE & Co. KGaA

Paths to Fresenius SE & Co. KGaA
Potential Connections via
Relationship Science
You
Fresenius SE & Co. KGaA
Owners & Shareholders
Details Hidden

AGI is an active manager which conducts in-house proprietary research to invest in public equity and fixed-income markets globally. The firm offers a range of investment strategies and styles. They make equity investments in value and growth stocks of companies across market-caps and typically invest in US convertibles, US high yield bonds and mortgage backed securities for fixed-income. They also make alternative investments. AGI has a strong focus on superior alpha-creation and modern risk management techniques are a primary concern.

Details Hidden

Brederode-IM is an active, long-term manager which aims to increase shareholder net worth by generating recurring dividend income and capital gains on investments.

Details Hidden

PCM is a global and international value equity manager. The firm employs an active, unconstrained (all countries, industries and market caps), value-oriented investment strategy. They employ a proprietary five factor global valuation model that produces a ranking of countries from the most undervalued to the most overvalued since country and industry factors have influences on security prices. The investment team conducts detailed fundamental research on the companies identified by the valuation screens. PCM’s research process is almost entirely driven by a world-wide search for undervalued common stocks of well-run companies with sustainable business models that are priced to provide their required rate of return. Most investments are held for three to five years resulting in low portfolio turnover. In the portfolio construction process, PCM seeks to include a broad range of market-caps in the portfolio but does not attempt to override the results of the bottom-up investment process.

Recent Transactions
Details Hidden

Fresenius SE & Co. KGaA, IDCQ Hospitales y Sanidad SL purchase Clinica Medellin SA

Details Hidden

HERMED Technische Beratungs GmbH, Fresenius SE & Co. KGaA purchase Avensys Uk Ltd.

Details Hidden

Fresenius SE & Co. KGaA, VAMED AG purchase Reha Seewis AG from Xard AG

Transaction Advisors
Legal Advisor

Advised onFresenius SE & Co. KGaA purchases APP Pharmaceuticals, Inc.

Legal Advisor

Advised onFresenius SE & Co. KGaA purchases Huangshi Lishizhen Med Group Wuhan Xisu Pharmaceutical Co Ltd. from Wuhan Lishizhen Medicine Co. Ltd.

Accountant

Advised onFresenius SE & Co. KGaA, Fresenius Kabi AG purchase Beijing Fresenius Kabi Pharmaceutical Co. Ltd. from China Resources Double-Crane Pharmaceutical Co., Ltd.

Legal Advisor

Advised onFresenius SE & Co. KGaA purchases APP Pharmaceuticals, Inc.

Legal Advisor

Advised onFresenius SE & Co. KGaA, HELIOS Kliniken GmbH purchase Rhön-Klinikum AG /Hospitals (40) from Rhön-Klinikum AG

Legal Advisor

Advised onFresenius SE & Co. KGaA, HELIOS Kliniken GmbH purchase Rhön-Klinikum AG /Hospitals (40) from Rhön-Klinikum AG

Advisors & Consultants
Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Legal Advisor

Partner at Skadden, Arps, Slate, Meagher & Flom LLP

Clients

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

Antares Pharma is a revenue-generating product focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA approved products. Our products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. We focus on self-injection pharmaceutical products and technologies and topical gel -based products. Our subcutaneous injection technology platforms include Vibex™ disposable pressure-assisted auto injectors, Vision® reusable needle-free injectors, and disposable multi-use pen injectors.

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Key Stats and Financials As of 2020
Market Capitalization
$23.6B
Total Enterprise Value
$60.9B
Earnings Per Share
$3.44
EBITDAMargin
19.49%
Enterprise Value / Sales
1.5x
Enterprise Value EBITDAOperating
7.67x
TEVNet Income
31.78x
Debt TEV
0.48x
Three Year Compounded Annual Growth Rate Of Revenue
2.3%
Revenue
$40.7B
Total Equity
$29.2B
Total Debt
$29.1B
EBITDA
$7.93B
Net Profit
$1.92B
Suppliers
Kendrion NV Auto Parts & Tires | Zeist, Netherlands

Kendrion NV engages in the development, manufacture, and marketing of electromagnetic components for industrial and automotive applications. It operates through the Automotive and Industrial business segments. The Automotive segment develops, manufactures, and markets electromagnetic components, mechatronics solutions, and sound systems for applications and customers. The Industrial segment offers the development and manufacture of electromagnetic and mechatronic systems and components for the process automation, energy generation and distribution, medical and analytical equipment, transportation, and aerospace markets. The company was founded by Wilhelm Binder in 1911 and is headquartered in Amsterdam, the Netherlands.

Cumberland Pharmaceuticals, Inc. Biotechnology | Nashville, Tennessee

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. Its product include Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Vibativ, and RediTrex. The company was founded by A. J. Kazimi on January 6, 1999 and is headquartered in Nashville, TN.

EKF Diagnostics Holdings Plc Medical Support Services | Penarth, United Kingdom

EKF Diagnostics Holdings Plc is a vitro diagnostics company, which designs and manufactures diagnostic equipment for use within point-of-care settings. It also sells benchtop analysers. It operates through the following segments: Germany, USA, Russia, and Others. The firm also manufactures liquid reagents, which are used in central laboratory analysers. Its product portfolio includes small blood analysers and associated consumables, used in testing patients for conditions including diabetes and anaemia. The company was founded in 1990 and is headquartered in Penarth, the United Kingdom.

Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

HCA Healthcare, Inc. Hospitals & Patient Services - Nashville, TN

HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. The company is headquartered in Nashville, TN.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Fresenius SE & Co. KGaA. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Fresenius SE & Co. KGaA's profile does not indicate a business or promotional relationship of any kind between RelSci and Fresenius SE & Co. KGaA.